One of the most common concerns families have after starting treatment is whether therapy needs to continue for the entire recommended course. Parents often search growth hormone therapy stopping early effects because they are wondering what happens if injections are paused, discontinued, or stopped before growth is complete.
The good news is that stopping growth hormone therapy does not cause a child to lose the height they have already gained.
However, ending treatment too early may reduce the total height benefit a child could have achieved if therapy had continued through the remainder of their growth years.
Growth hormone therapy is designed to work gradually over time. The greatest benefits often occur through years of consistent treatment rather than a short burst of rapid growth.
Understanding why treatment duration matters can help families make informed decisions and avoid unintentionally limiting a child's final height potential.
Why Growth Hormone Therapy Is Usually a Long-Term Treatment
Many parents are surprised to learn that HGH for children to grow taller is rarely a short-term therapy.
Growth occurs slowly throughout childhood and adolescence.
Most children remain on treatment until:
- Growth goals are reached
- Growth plates close
- Growth velocity becomes minimal
- Providers determine further benefit is unlikely
Depending on age and diagnosis, treatment may continue for several years.
This long-term approach allows children to take advantage of the remaining growth potential available before skeletal maturity occurs.
Why Timing Matters So Much
The effectiveness of growth hormone therapy depends on one important factor:
Remaining growth potential.
Children can only gain height while their growth plates remain open.
Growth plates are specialized areas of cartilage located near the ends of long bones.
These structures allow bones to lengthen during childhood and adolescence.
Eventually growth plates mature and close.
Once closure occurs:
- Height growth stops
- Growth hormone can no longer increase height
- Remaining growth opportunities disappear
This is why specialists focus heavily on treatment timing.
Stopping therapy before growth plates close may leave valuable growth potential unused.
What Happens Immediately After Stopping Growth Hormone Therapy?
Parents often worry that stopping treatment will cause withdrawal symptoms.
Fortunately, this is generally not what happens.
Growth hormone therapy does not create a typical withdrawal syndrome.
Instead, the body gradually returns to its natural hormone production pattern.
For most children, the immediate effects are relatively mild.
Slower Growth Velocity
One of the first changes may be a reduction in poor growth velocity improvement that was achieved during treatment.
Growth often slows toward the child's underlying baseline pattern.
Return Toward Previous Growth Trends
Children with conditions such as growth hormone deficiency may gradually return toward their original growth trajectory.
Appetite Changes
Some children experience mild changes in appetite as growth rates decrease.
No Loss of Height Already Gained
Importantly, children keep the height they gained during treatment.
The concern is future growth—not loss of existing growth.
The Most Important Long-Term Effect: Reduced Adult Height
The primary concern associated with stopping treatment too early is reduced final height potential.
Missing Remaining Growth Years
If therapy ends while substantial growth time remains:
- Future growth may be reduced
- Adult height predictions may decline
- The child may not fully reach their genetic potential
Parents frequently ask:
The answer often depends not only on starting treatment but also on continuing therapy long enough to maximize available growth opportunities.
Growth Opportunity Cannot Be Recovered Later
Once growth plates close, additional height gain is generally no longer possible.
This means lost growth years cannot usually be regained later.
What Happens to Growth Percentiles?
Another possible consequence of stopping treatment early is a decline in growth percentile ranking.
Children with:
- growth hormone deficiency
- low IGF-1
- pituitary disorders
- severe idiopathic short stature
may experience slowing growth after discontinuation.
As peers continue growing, some children may gradually fall on growth charts.
This does not happen in every case, but it is one reason why ongoing monitoring is important.
Does Stopping Therapy Affect Puberty?
In most cases, puberty continues normally after growth hormone therapy ends.
Growth hormone treatment does not control puberty itself.
However, changes in growth progression may influence how growth and development appear during adolescence.
Children with:
often have different growth timelines than their peers regardless of treatment status.
This is another reason why individualized care is important.
Conditions Where Stopping Early May Have Greater Consequences
Some diagnoses are more dependent on long-term treatment than others.
Growth Hormone Deficiency
Children with confirmed growth hormone deficiency often benefit most from maintaining therapy until growth goals are reached.
Pituitary Disorders
Children with pituitary disorders may rely on ongoing hormone support to maintain normal growth patterns.
Low IGF-1
Children with low IGF-1 may experience reduced growth signaling if treatment ends prematurely.
Severe Idiopathic Short Stature
Some children with idiopathic short stature may lose part of their expected height benefit if therapy is stopped early.
When Is It Appropriate to Stop Growth Hormone Therapy?
Stopping therapy is not always a bad thing.
In fact, there are situations where discontinuation is completely appropriate.
Growth Plates Have Closed
One of the most common reasons treatment ends.
A bone age assessment helps determine when growth plate closure has occurred.
Growth Velocity Has Become Minimal
When height gains become very small, continued treatment may offer limited benefit.
Treatment Goals Have Been Reached
Some children successfully achieve desired growth outcomes before full skeletal maturity.
Medical Reasons
Occasionally, treatment plans change because of medical considerations or family decisions.
The key is ensuring the decision is guided by objective growth data rather than guesswork.
Why Bone Age Assessment Matters Before Stopping
Chronological age alone does not determine whether treatment should continue.
A 14-year-old may still have significant growth potential remaining.
Another 14-year-old may be nearly finished growing.
This is why providers often perform a:
bone age assessment
to evaluate:
- Skeletal maturity
- Growth plate status
- Remaining growth potential
- Expected future growth
Children with a delayed bone age frequently have more growth remaining than parents realize.
How Doctors Decide Whether Treatment Should Continue
Specialists evaluate several factors together.
Growth Velocity Trends
Current growth rates provide valuable information.
Puberty Progression
Puberty strongly influences remaining growth time.
Bone Age Imaging
A bone age assessment helps estimate how much growth remains.
Height Prediction
Many families begin treatment after learning projected adult height may be lower than expected.
Ongoing evaluations help determine whether continued treatment remains beneficial.
Medical Necessity
Providers continue assessing growth hormone therapy medical necessity criteria throughout treatment.
Frequently Asked Questions
Will my child lose height if growth hormone therapy stops?
No. Height already gained is maintained. The concern is reduced future growth.
Can treatment be restarted later?
Sometimes, but height opportunities lost after growth plate closure generally cannot be recovered.
How do doctors know when to stop therapy?
They evaluate growth velocity, puberty progression, and findings from a bone age assessment.
Does stopping growth hormone affect puberty?
Usually no. Puberty generally continues according to the child's natural developmental timeline.
What is the biggest risk of stopping early?
The biggest concern is reduced final adult height due to lost growth opportunities.
The Bottom Line
The primary growth hormone therapy stopping early effects involve reduced future growth rather than harm.
Children keep the height they have already gained, but stopping treatment prematurely may reduce final adult height if significant growth potential remains.
This is why ongoing monitoring is so important. Providers use growth measurements, puberty assessments, and bone age assessment findings to determine the ideal time to continue—or discontinue—therapy.
Whether a child is being treated for growth hormone deficiency, idiopathic short stature, low IGF-1, pituitary disorders, or another growth-related condition, careful timing helps maximize the opportunity to reach their natural height potential before growth plates close.
Medically Reviewed By
Dr. Devin Stone, ND
Dr. Devin Stone is a Doctor of Naturopathic Medicine and founder of HGHforChildren.com. His clinical focus includes pediatric growth optimization, growth hormone deficiency, delayed bone age assessment, constitutional growth delay, IGF-1 evaluation, and evidence-informed therapies designed to help children maximize healthy growth potential.
References
- Pediatric Endocrine Society. Growth Hormone Treatment Resources.
- Growth Hormone Research Society Consensus Guidelines.
- Endocrine Society Clinical Practice Guidelines.
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
- Hormone Research in Paediatrics.
- American Academy of Pediatrics. Growth Disorders and Treatment Monitoring.
- National Institutes of Health (NIH). Growth Hormone Therapy Information.
- Grimberg A, et al. Guidelines for Growth Hormone and IGF-1 Treatment in Children and Adolescents.
Dr. Devin Stone
Contact Me
